Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease

Abstract

Autosomal dominant tubulointerstitial kidney disease (ADTKD)-uromodulin ( UMOD) is an underdiagnosed cause of chronic kidney disease (CKD). Lack of ultrasensitive bioanalytical tools has hindered the discovery of low abundant urinary biomarkers in ADTKD. Here, we developed an ultrasensitive plasmon-enhanced fluorescence-linked immunosorbent assay (p-FLISA). p-FLISA demonstrated that secreted immunoglobulin heavy chain-binding protein is an early urinary endoplasmic reticulum stress biomarker in ADTKD- UMOD, which will be valuable in monitoring disease progression and the treatment response in ADTKD.

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2021
Source ID
10.1152/ajprenal.00231.2021

Entities

People

  • Anthony J Bleyer
  • Bryce G. Johnson
  • Chuang Li
  • Jeremiah J Morrissey
  • Jeremy S. Duffield
  • Kendrah Kidd
  • Srikanth Singamaneni
  • Stanislav Kmoch
  • Yeawon Kim
  • Ying Maggie Chen
  • Yixuan Wang
  • Zheyu Wang

Organizations

  • Charles University
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Pfizer
  • United States Department of Defense
  • Wake Forest School of Medicine
  • Washington University School of Medicine
  • Washington University in St. Louis

Tags

Fields of Study

  • Medicine

Readers

  • Molecular and Cellular Biology
  • Nanoscale Plasmonic Nanotechnology
  • Oncology and Biomarker-Based Cancer Detection.